The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.

MLA

Morley, K. C., et al. “The Efficacy and Biobehavioural Basis of Baclofen in the Treatment of Alcoholic Liver Disease (BacALD): Study Protocol for a Randomised Controlled Trial.” Contemporary Clinical Trials, vol. 36, no. 2, Nov. 2013, pp. 348–55. EBSCOhost, https://doi.org/10.1016/j.cct.2013.08.002.

APA

Morley, K. C., Leung, S., Baillie, A., & Haber, P. S. (2013). The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial. Contemporary Clinical Trials, 36(2), 348–355. https://doi.org/10.1016/j.cct.2013.08.002

Chicago

Morley, K C, S Leung, A Baillie, and P S Haber. 2013. “The Efficacy and Biobehavioural Basis of Baclofen in the Treatment of Alcoholic Liver Disease (BacALD): Study Protocol for a Randomised Controlled Trial.” Contemporary Clinical Trials 36 (2): 348–55. doi:10.1016/j.cct.2013.08.002.